by Nestlé, who else? Colombian president Juan Manuel Santos (r) drinks a coffee with Nespresso CEO Jean-Marc Duvoisin in Bogota in November. With a market value of 4 billion (CHF258 billion), Nestlé has claimed second place in Europe behind Royal Dutch Shell (6 billion) in global rankings published by consultancy EY on Friday. However, that only put them in 17th and 18th place respectively, well below the global ranking leaders: the Silicon Valley tech giants Apple (6 billion), Alphabet (3 billion) and Microsoft (1 billion). + Read how Nestlé sets target for increasing profit margins EY reported that Chinese companies had muscled their way past European firms, with some entering the top ten for the first
Topics:
Swissinfo considers the following as important: Business, Featured, newsletter, Swiss Markets and News
This could be interesting, too:
Eamonn Sheridan writes CHF traders note – Two Swiss National Bank speakers due Thursday, November 21
Charles Hugh Smith writes How Do We Fix the Collapse of Quality?
Marc Chandler writes Sterling and Gilts Pressed Lower by Firmer CPI
Michael Lebowitz writes Trump Tariffs Are Inflationary Claim The Experts
Nestlé, who else? Colombian president Juan Manuel Santos (r) drinks a coffee with Nespresso CEO Jean-Marc Duvoisin in Bogota in November.
With a market value of $264 billion (CHF258 billion), Nestlé has claimed second place in Europe behind Royal Dutch Shell ($276 billion) in global rankings published by consultancy EY on Friday.
However, that only put them in 17th and 18th place respectively, well below the global ranking leaders: the Silicon Valley tech giants Apple ($876 billion), Alphabet ($733 billion) and Microsoft ($661 billion).
+ Read how Nestlé sets target for increasing profit margins
EY reported that Chinese companies had muscled their way past European firms, with some entering the top ten for the first time. The internet services company Tencent Holdings ($484 billion) and e-commerce firm Alibaba Group ($444 billion) were ranked 7th and 8th, having doubled their market capitalisation in 2017.
Pharma
Switzerland’s two big pharma companies, Roche and Novartis, were the only other Swiss firms to make it into EY’s top 100. Roche came 31st with a value of $213 billion while cross-town rival Novartis was six places lower with $195 billion.
The country’s biggest banks, UBS and Credit Suisse, only managed 153rd and 279th positions respectively.
Overall, the cumulative market value of the world’s 100 most expensive companies rose by almost 26% to $20.2 trillion over the past 12 months.
Tags: Business,Featured,newsletter